Structural diversity of neuritogenic substances and their application perspective

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 8, 2011, Pages 658-677

  Qi, J ^a   Luo, Y ^a   Gao, L ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Natural products; Nerve growth factor; Neuritogenic substances; Neuronal cells; Neurotrophic factors

Indexed keywords

1 ALKYLOXYGENIPIN; ALKALOID DERIVATIVE; CLERODANE DERIVATIVE; DITERPENE; DITERPENOID; GENIPIN; GENIPOSIDE; GLYCOSIDE; HYDROXY 3,4 DEHYDRONEOMAJUCIN; IRIDOID; ISOPROPYLOXYGENIPIN; JIADIFENIN; LACTONE DERIVATIVE; LIPID; MERRILACTONE A; NEOVIBSANIN; NEOVIBSANIN A; NEOVIBSANIN B; NEURITOGENIC AGENT; NEUROTROPIC AGENT; PICROSIDE I; PICROSIDE II; PLANT GLYCOSIDE; SESQUITERPENE DERIVATIVE; STAUROSPORINE; STEROID GLYCOSIDE; TERPENE DERIVATIVE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; MEDICINAL PLANT; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; OXIDATIVE STRESS; STRUCTURE ACTIVITY RELATION;

EID: 79960469174     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711796268796     Document Type: Article

References (142)

1. Bharadwaj, P.R.; Dubey, A.K.; Masters, C.L.; Martins, R.N.; Macreadie, I.G. A aggregation and possible implications in Alzheimer's disease pathogenesis. J. Cell. Mol. Med., 2009, 13, 412-21.
2. Re, F.; Airoldi, C.; Zona, C.; Masserini, M.; La Ferla, B.; Quattrocchi, N.; Nicotra, F. Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. Curr. Med. Chem., 2010, 17, 2990-3006.
3. Roberson, E.D.; Mucke, L. 100 Years and counting: prospects for defeating Alzheime's disease. Science, 2006, 314, 781-84.
4. Sabbagh, M.N. Drug development for Alzheimer's disease: where are we now and where are we headed? Am. J. Geriatr. Pharmacother., 2009, 7, 167-85.
5. Lee, H.P.; Zhu, X.W.; Casadesus, G.; Castellani, R.J.; Nunomura, A.; Smith, M.A.; Lee, H.G.; Perry, G. Antioxidant approaches for the treatment of Alzheimer's disease. Expert. Rev. Neurother., 2010, 10, 1201-08.
6. Salminen, A.; Ojala, J.; Kauppinen, A.; Kaarniranta, K.; Suuronen, T. Inflammation in Alzheimer's disease: amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors, Prog. Neurobiol., 2009, 87, 181-94.
7. Jeganathan, S.; von Bergen, M.; Mandelkow, E.M.; Mandelkow, E. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. Biochemistry, 2008, 47, 10526-39.
8. Moreira, P.I.; Zhu, X.W.; Wang, X.L.; Lee, H.G.; Nunomura, A.; Petersen, R.B.; Perry, G.; Smith, M.A. Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta-Mol. Basis Dis., 2010, 1802, 212-20.
9. Lleó, A.; Greenberg, S.M.; Growdon, J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med., 2006, 57, 513-33.
10. Donev, R.; Kolev, M.; Millet, B.; Thome, J. Neuronal death in Alzheimer's disease and therapeutic opportunities. J. Cell. Mol. Med., 2009, 13, 4329-48.
11. Thoenen, H. Neurotrophins and neuronal plasticity. Science, 1995, 270, 593-98.
12. Berninger, B.; Poo, M.M. Exciting neurotrophins. Nature, 1999, 401, 862-63.
13. Kromer, L.F. Nerve growth factor treatment after brain injury prevents neuronal death. Science, 1987, 235, 214-16.
14. Brinton, R.D.; Yamazaki, R.S. Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharm. Res., 1998, 15, 386-98.
15. Li, Y.Y.; Hu, Z.Y.; Lu, C.H.; Shen, Y.M. Four new terpenoids from Xylaria sp. 101. Helv. Chim. Acta, 2010, 93, 796-802.
16. Robinson, A.; Kumar, T.V.; Sreedhar, E.; Naidu, V.G.M.; Krishna, S.R.; Babu, K.S.; Srinivas, P.V.; Rao, J.M. A new sesquiterpene lactone from the roots of Saussurea lappa: structure-anticancer activity study. Bioorg. Med. Chem. Lett., 2008, 18, 4015-17.
17. Chen, B.W.; Chao, C.H.; Su, J.H.; Wen, Z.H.; Sung, P.J.; Sheu, J.H. Anti-inflammatory eunicellin-based diterpenoids from the cultured soft coral Klyxum simplex. Org. Biomol. Chem., 2010, 8, 2363-66.
18. Liebgott, T.; Miollan, M.; Berchadsky, Y.; Drieu, K.; Culcasi, M.; Pietri, S. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res. Cardiol., 2000, 95, 368-77.
19. Li, C.J.; Zhang, D.M.; Luo, Y.M.; Yu, S.S.; Li, Y.; Lu, Y. Bissesquiterpenes and diterpenes from Chloranthus henryi. Phytochemistry, 2008, 69, 2867-74.
20. Tundis, R.; Loizzo, M.R.; Menichini, F.; Statti, G.A.; Menichini, F. Biological and pharmacological activities of iridoids: recent developments. Mini-Rev. Med. Chem., 2008, 8, 399-420.
21. Inouye, H.; Saito, S. New iridiglucosides gardenoside and genipinside from Gardenia jasminoides. Tetrahedron Lett., 1969, 28, 2347-50.
22. Yamazaki, M.; Chiba, K.; Mohri, T. Neuritogenic effect of natural iridoid compounds on PC12h cells and its possible relation to signaling protein kinases. Biol. Pharm. Bull., 1996, 19, 791-95.
23. Chiba, K.; Yamazaki, M.; Kikuchi, M.; Machida, K.; Kikuchi, M. Neuritogenesis of herbal geniposide-related compounds in PC12h cells. J. Health Sci., 2006, 52, 743-47.
24. Liu, J.H.; Zheng, X.X.; Yin, F.; Hu, Y.H.; Guo, L.X.; Deng, X.H.; Chen, G.; Jing, J.J.; Zhang, H. Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells. Int. J. Devl Neuroscience, 2006, 24, 419-24.
25. Liu, J.H.; Yin, F.; Guo, L.X.; Deng, X.H.; Hu, Y.H. Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway. Acta Pharmacol. Sin., 2009, 30, 159-65.
26. Yin, F.; Liu, J.H.; Xiao, H.; Kong, S.Z. Geniposide prevents PC12 cells from peroxynitrite via the mitogen-activated protein kinase signaling pathway. J. Health Sci., 2010, 56, 195-99.
27. Yamazaki, M.; Chiba, K. Neurotrophic effects of genipin on Neuro 2a cells. J. Health Sci., 2005, 51, 687-92.
28. Yamazaki, M.; Chiba, K. Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthaseexpressing cells. Eur. J. Pharmacol., 2008, 581, 255-61.
29. Yamazaki, M.; Sakura, N.; Chiba, K.; Mohri, T. Prevention of the neurotoxicity of the amyloid ß protein by genipin. Biol. Pharm. Bull., 2001, 24, 1454-55.
30. Yamazaki, M.; Chiba, K.; Satoh, K. Neuro2a cell death induced by 6-hydroxydopamine is attenuated by genipin. J. Health Sci., 2008, 54, 638-44.
31. Ohkubo, T.; Yamazaki, M.; Yoshida, A.; Chiba, K.; Mohri, T. Detection of genipin/geniposide-target molecules by a geniposide overlay method using anti-geniposide antibody. J. Health Sci., 2004, 50, 193-96.
32. Hou, Y.C.; Tsai, S.Y.; Lai, P.Y.; Chen, Y.S.; Chao, P.D.L. Metabolism and pharmacokinetics of genipin and geniposide in rats. Food Chem. Toxicol., 2008, 46, 2764-69.
33. Suzuki, H.; Yamazaki, M.; Chiba, K.; Uemori, Y.; Sawanishi, H. Neuritogenic activities of 1-alkyloxygenipins. Chem. Pharm. Bull., 2010, 58, 168-71.
34. Li, P.; Matsunaga, K.; Yamakuni, T.; Ohizumi, Y. Potentiation of nerve growth factor-action by picrosides I and II, natural iridoids, in PC12D cells. Eur. J. Pharmacol., 2000, 406, 203-08.
35. Li, P.; Matsunaga, K.; Yamakuni, T.; Ohizumi, Y. Picrosides I and II, selective enhancers of the mitogen-activated protein kinasedependent signaling pathway in the action of neuritogenic substances on PC12D cells. Life Sci., 2002, 71, 1821-35.
36. Kouno, I.; Baba, N.; Hashimoto, M.; Kawano, N.; Takahashi, M.; Kaneto, H.; Yang, C.S. Sesquiterpene lactones from the pericarps of Illicium majus; 2-oxy derivatives of neomajucin and 3,4- dehydroxyneomajucin. Chem. Pharm. Bull., 1990, 38, 422-25.
37. Yokoyama, R.; Huang, J.M.; Yang, C.S.; Fukuyama, Y. New secoprezizaane- type sesquiterpenes, jiadifenin with neurotrophic activity and 1,2-dehydroneomajucin from Illicium jiadifengpi. J. Nat. Prod., 2002, 65, 527-31.
38. Cho, Y.S.; Carcache, D.A.; Tian, Y.; Li, Y.M.; Danishefsky, S.J. Total synthesis of (±)-jiadifenin, a non-peptidyl neurotrophic modulator. J. Am. Chem. Soc., 2004, 126, 14358-59.
39. Carcache, D.A.; Cho, Y.S.; Hua, Z.H.; Tian, Y.; Li, Y.M.; Danishefsky, S.J. Total synthesis of (±)-jiadifenin and studies directed to understanding its SAR: probing mechanistic and stereochemical issues in palladium-mediated allylation of enolatelike structures. J. Am. Chem. Soc., 2006, 128, 1016-22.
40. Huang, J.M.; Yokoyama, R.; Yang, C.S.; Fukuyama, Y. Merrilactone A, a novel neurotrophic sesquiterpene dilactone from Illicium merrillianum. Tetrahedron Lett., 2000, 41, 6111-14.
41. Huang, J.M.; Yang, C.S.; Tanaka, M.; Fukuyama, Y. Structures of merrilactones B and C, novel anislactone-type sesquiterpenes from Illicium merrillianum, and chemical conversion of anislactone B to merrilactone A. Tetrahedron, 2001, 57, 4691-98.
42. Birman, V.B.; Danishefsky, S.J. The total synthesis of (±)- merrilactone A. J. Am. Chem. Soc., 2002, 124, 2080-81.
43. Inoue, M.; Sato, T.; Hirama, M. Total synthesis of merrilactone A. J. Am. Chem. Soc., 2003, 125, 10772-73.
44. Iriondo-Alberdi, J.; Perea-Buceta, J.E.; Greaney, M.F. A Paternò- Büchi approach to the synthesis of merrilactone A. Org. Lett., 2005, 7, 3969-71.
45. Fukuyama, Y.; Minami, H.; Takeuchi, K.; Kodama, M.; Kawazu, K. Neovibsanines A and B, unprecedented diterpenes from Viburnum awabuki. Tetrahedron Lett., 1996, 37, 6767-70.
46. Esumi, T.; Zhao, M.; Kawakami, T.; Fukumoto, M.; Toyota, M.; Fukuyama, Y. Synthetic studies toward neovibsanins A and B: construction of the neovibsanin core utilizing palladium(0)- catalyzed carbonylative cyclization with carbon monoxide. Tetrahedron Lett., 2008, 49, 2692-96.
47. Kubo, M.; Kishimoto, Y.; Harada, K.; Hioki, H.; Fukuyama, Y. NGF-potentiating vibsane-type diterpenoids from Viburnum sieboldii. Bioorg. Med. Chem. Lett., 2010, 20, 2566-71.
48. Chen, A.P.J.; Müller, C.C.; Cooper, H.M.; Williams, C.M. Synthetic neovibsanes and their ability to induce neuronal differentiation in PC12 cells. Tetrahedron, 2010, 66, 6842-50.
49. Tang, W.X.; Kubo, M.; Harada, K.; Hioki, H.; Fukuyama, Y. Novel NGF-potentiating diterpenoids from a Brazilian medicinal plant, Ptychopetalum olacoides. Bioorg. Med. Chem. Lett., 2009, 19, 882-86.
50. Calon, F.; Lim, G.P.; Yang, F.S.; Morihara, T.; Teter, B.; Ubeda, O.; Rostaing, P.; Triller, A.; Salem, N.; Ashe, K.H.; Frautschy, S.A.; Cole, G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron, 2004, 43, 633-45.
51. Lukiw, W.J.; Cui, J.G.; Marcheselli, V.L.; Bodker, M.; Botkjaer, A.; Gotlinger, K.; Serhan, C.N.; Bazan, N.G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease, J. Clin. Invest., 2005, 115, 2774-83.
52. Kaur, P.; Schulz, K.; Aschner, M.; Syversen, T. Role of docosahexaenoic acid in modulating methylmercury-induced neurotoxicity. Toxicol. Sci., 2007, 100, 423-32.
53. Ikemoto, A.; Kobayashi, T.; Watanabe, S.; Okuyama, H. Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. Neurochem. Res., 1997, 22, 671-78.
54. Calderon, F.; Kim, H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem., 2004, 90, 979-88.
55. Cao, D.H.; Xue, R.H.; Xu, J.; Liu, Z.L. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J. Nutr. Biochem., 2005, 16, 538-46.
56. Shimazawa, M.; Nakajima, Y.; Mashima, Y.; Hara, H. Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res., 2009, 1251, 269-75.
57. Marszalek, J.R.; Kitidis, C.; Dirusso, C.C.; Lodish, H.F. Longchain acyl-CoA synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem., 2005, 280, 10817-26.
58. Dagai, L.; Peri-Naor, R.; Birk, R.Z. Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth. Neurochem. Res., 2009, 34, 867-75.
59. Aoki, S.; Matsui, K.; Tanaka, K.; Satari, R.; Kobayashi, M. Lembehyne A, a novel neuritogenic polyacetylene, from a marine sponge of Haliclona sp. Tetrahedron, 2000, 56, 9945-48.
60. Aoki, S.; Matsui, K.; Wei, H.; Murakami, N.; Kobayashi, M. Structure-activity relationship of neuritogenic spongean acetylene alcohols, lembehynes. Tetrahedron, 2002, 58, 5417-22.
61. Murakami, N.; Nakajima, T.; Kobayashi, M. Total synthesis of lembehyne A, a neuritogenic spongean polyacetylene. Tetrahedron Lett., 2001, 42, 1941-43.
62. Aoki, S.; Matsui, K.; Takata, T.; Kobayashi, M. In situ photoaffinity labeling of the target protein for lembehyne A, a neuronal differentiation inducer. FEBS Lett., 2003, 544, 223-27.
63. Ledeen, R.W. Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res., 1984, 12, 147-59.
64. Matsuoka, Y.; Saito, M.; LaFrancois, J.; Saito, M.; Gaynor, K.; Olm, V.; Wang, L.L.; Casey, E.; Lu, Y.F.; Shiratori, C.; Lemere, C.; Duff, K. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta amyloid. J. Neurosci., 2003, 23, 29-33.
65. Svennerholm, L.; Bråne, G.; Karlsson, I.; Lekman, A.; Ramström, I.; Wikkelsö, C. Alzheimer disease-effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr Cogn Disord, 2002, 14, 128-36.
66. Higuchi, R.; Inagaki, M.; Yamada, K.; Miyamoto, T. Biologically active gangliosides from echinoderms. J. Nat. Med., 2007, 61, 367-70.
67. Kaneko M.; Yamada, K.; Miyamoto, T.; Inagaki, M.; Higuchi, R. Neuritogenic activity of gangliosides from echinoderms and their structure-activity relationship. Chem. Pharm. Bull., 2007, 55, 462-63.
68. Arao, K.; Inagaki, M.; Higuchi, R. Constituents of crinoidea. 2, isolation and structure of the novel type gangliosides from the feather star Comanthus japonica. Chem. Pharm. Bull., 2001, 49, 695-98.
69. Arao, K.; Inagaki, M.; Miyamoto, T.; Higuchi, R. Constituents of crinoidea. 3. isolation and structure of a glycosyl inositolphosphoceramide-type ganglioside with neuritogenic activity from the feather star Comanthus japonica. Chem. Pharm. Bull., 2004, 52, 1140-42.
70. Kisa, F.; Yamada, K.; Miyamoto, T.; Inagaki, M.; Higuchi, R. Constituents of holothuroidea, 17. isolation and structure of biologically active monosialo-gangliosides from the sea cucumber Cucumaria echinata. Chem. Pharm. Bull., 2006, 54, 982-87.
71. Yamada, K.; Hamada, A.; Kisa, F.; Miyamoto, T.; Higuchi, R. Constituents of holothuroidea, 13. structure of neuritogenic active ganglioside molecular species from the sea cucumber Stichopus chloronotus. Chem. Pharm. Bull., 2003, 51, 46-52.
72. Yamada, K.; Tanabe, K.; Miyamoto, T.; Kusumoto, T.; Inagaki, M.; Higuchi, R. Isolation and structure of a monomethylated ganglioside possessing neuritogenic activity from the ovary of the sea urchin Diadema setosum. Chem. Pharm. Bull., 2008, 56, 734-37.
73. Kisa, F.; Yamada, K.; Miyamoto, T.; Inagaki, M.; Higuchi, R. Constituents of holothuroidea, 18. isolation and structure of biologically active disialo- and trisialo-gangliosides from the sea cucumber Cucumaria echinata. Chem. Pharm. Bull., 2006, 54, 1293-98.
74. Tan, R.X.; Che, J.H. The cerebrosides. Nat. Prod. Rep., 2003, 20, 509-34.
75. Qi, J.H.; Ojika, M.; Sakagami, Y.J. Termitomycesphins A-D, novel neuritogenic cerebrosides from the edible Chinese mushroom Termitomyces albuminosus. Tetrahedron, 2000, 56, 5835-41.
76. Qi, J.H.; Ojika, M.; Sakagami, Y.J. Neuritogenic cerebrosides from an edible Chinese mushroom. part 2: structures of two additional termitomycesphins and activity enhancement of an inactive cerebroside by hydroxylation. Bioorg. Med. Chem., 2001, 9, 2171-77.
77. Gao, L.J.; Li, J.Y.; Qi, J.H. Gentisides A and B, two new neuritogenic compounds from the traditional Chinese medicine Gentiana rigescens Franch. Bioorg. Med. Chem., 2010, 18, 2131-34.
78. Gao, L.J.; Xiang, L.; Luo, Y.; Wang, G.F.; Li, J.Y.; Qi, J.H. Gentisides C-K: nine new neuritogenic compounds from the traditional Chinese medicine Gentiana rigescens Franch. Bioorg. Med. Chem., 2010, 18, 6995-7000.
79. Kakeya, H.; Takahashi, I.; Okada, G.; Isono, K.; Osada, H. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus. J. Antibiot., 1995, 48, 733-35.
80. Kakeya, H.; Onozawa, C.; Sato, M.; Arai, K.; Osada, H. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors. J. Med. Chem., 1997, 40, 391-94.
81. Marumoto, S.; Kogen, H.; Naruto, S. Absolute configuration and total synthesis of (+)-epolactaene, a neuritogenic agent from Penicillium sp. BM 1689-P active in human neuroblastoma cells. J. Org. Chem., 1998, 63, 2068-69.
82. Hayashi, Y.; Narasaka, K. Asymmetric total synthesis of epolactaene. Chem. Lett., 1998, 4, 313-14.
83. Mizushima, Y.; Kobayashi, S.; Kuramochi, K.; Nagata, S.; Sugawara, F.; Sakaguchi, K. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II. Biochem. Biophys. Res. Commun., 2000, 273, 784-88.
84. Hayashi, Y.; Kanayama, J.; Yamaguchi, J.; Shoji, M. Diastereoselective total synthesis of both enantiomers of epolactaene. J. Org. Chem., 2002, 67, 9443-48.
85. Kuramochi, K.; Nagata, S.; Itaya, H.; Matsubara, Y.; Sunoki, T.; Uchiro, H.; Takao, K.; Kobayashi, S. A convergent total synthesis of epolactaene: an application of the bridgehead oxiranyl anion strategy. Tetrahedron, 2003, 59, 9743-58.
86. Tan, Z.; Negishi, E. Selective synthesis of epolactaene featuring efficient construction of methyl (Z)-2-iodo-2-butenoate and (2R,3S,4S)-2-trimethylsilyl-2,3-epoxy-4-methyl-β-butyrolactone. Org. Lett., 2006, 8, 2783-85.
87. Schmidt, K.; Günther, W.; Stoyanova, S.; Schubert, B.; Li, Z.Z.; Hamburger, M. Militarinone A, a neurotrophic pyridone alkaloid from Paecilomyces militaris. Org. Lett., 2002, 4, 197-99.
88. Schmidt, K.; Riese, U.; Li, Z.Z.; Hamburger, M. Novel tetramic acids and pyridone alkaloids, militarinones B, C, and D, from the insect pathogenic fungus Paecilomyces militaris. J. Nat. Prod., 2003, 66, 378-83.
89. Cheng, Y.X.; Schneider, B.; Riese, U.; Schubert, B.; Li, Z.Z.; Hamburger, M. (+)-N-Deoxymilitarinone A, a neuritogenic pyridone alkaloid from the insect pathogenic fungus Paecilomyces farinosus. J. Nat. Prod., 2006, 69, 436-38.
90. Riese, U.; Ziegler, E.; Hamburger, M. Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways. FEBS Lett., 2004, 577, 455-59.
91. Küenzi, P.; Kiefer, S.; Koryakina, A.; Hamburger, M. Promotion of cell death or neurite outgrowth in PC-12 and N2a cells by the fungal alkaloid militarinone A depends on basal expression of p53. Apoptosis, 2008, 13, 364-76.
92. Cheng, Y.X.; Schneider, B.; Riese, U.; Schubert, B.; Li, Z.Z.; Hamburger, M. Farinosones A-C, neurotrophic alkaloidal metabolites from the entomogenous deuteromycete Paecilomyces farinosus. J. Nat. Prod., 2004, 67, 1854-58.
93. Jessen, H.J.; Barbaras, D.; Hamburger, M.; Gademann, K. Total synthesis and neuritotrophic activity of farinosone C and derivatives. Org. Lett., 2009, 11, 3446-49.
94. Aoki, S.; Wei, H.; Matsui, K.; Rachmat, R.; Kobayashi, M. Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis. Bioorg. Med. Chem., 2003, 11, 1969-73.
95. Sakai, R.; Higa, T. Manzamine A, a novel antitumor alkaloid from a sponge. J. Am. Chem. Soc., 1986, 108, 6404-05.
96. Zhang, B.; Higuchi, R.; Miyamoto, T.; Van Soest, R.W.M. Neuritogenic activity-guided isolation of a free base form manzamine A from a marine sponge, Acanthostrongylophora aff. ingens (Thiele, 1899). Chem. Pharm. Bull., 2008, 56, 866-69.
97. Qi, J.H.; Ojika, M.; Sakagami, Y. Linckosides A and B, two new neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorg. Med. Chem., 2002, 10, 1961-66.
98. Qi, J.H.; Ojika, M.; Sakagami, Y. Linckosides C-E, three new neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorg. Med. Chem., 2004, 12, 4259-65.
99. Han, C.G.; Qi, J.H.; Ojika, M. Structure-activity relationships of novel neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorg. Med. Chem., 2006, 14, 4458-65.
100. Han, C.G.; Qi, J.H.; Ojika, M. Linckosides M-Q: neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. J. Nat. Med., 2007, 61, 138-45.
101. Pizza, C.; Minale, L.; Laurent, D.; Menou, J.L. Starfish saponins. 27. steroidal glycosides from the starfish Choriaster-granulatus. Gazz. Chim. Ital., 1985, 115, 585-89.
102. Qi, J.H.; Han, C.G.; Sasayama, Y.; Nakahara, H.; Shibata, T.; Uchida, K.; Ojika, M. Granulatoside A, a starfish steroid glycoside, enhances PC12 cell neuritogenesis induced by nerve growth factor through an activation of MAP kinase. ChemMedChem, 2006, 1, 1351-54.
103. Hur, J.Y.; Lee, P.; Moon, E.J.; Kang, I.; Kim, S.H.; Oh, M.S.; Kim, S.Y. Neurite outgrowth induced by spicatoside A, a steroidal saponin, via the tyrosine kinase A receptor pathway. Eur. J. Pharmacol., 2009, 620, 9-15.
104. Nozawa, Y.; Sakai, N.; Matsumoto, K.; Mizoue, K. A novel neuritogenic compound, NGA0187. J. Antibiotics., 2002, 55, 629-34.
105. Hua, Z.H.; Carcache, D.A.; Tian, Y.; Li, Y.M.; Danishefsky, S.J. The synthesis and preliminary biological evaluation of a novel steroid with neurotrophic activity: NGA0187. J. Org. Chem., 2005, 70, 9849-56.
106. Miyata, A.; Arimura, A.; Dahl, R.R.; Minamino, N.; Uehara, A.; Jiang, L.; Culler, M.D.; Coy, D.H. Isolation of a novel-38 residuehypothalamic polypeptide which stimulates adenylate-cyclase in pituitary-cells. Biochem. Biophys. Res. Commun., 1989, 164, 567-74.
107. Vaudry, D.; Gonzalez, B.J.; Basille, M.; Yon, L.; Fournier, A.; Vaudry, H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev., 2000, 52, 269-324.
108. Deutsch, P.J.; Schadlow, V.C.; Barzilai, N. 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells. J. Neurosci. Res., 1993, 35, 312-20.
109. Wolf, N.; Krieglstein, K. Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide. Neurosci. Lett., 1995, 200, 207-10.
110. Hernandez, A.; Kimball, B.; Romanchuk, G.; Mulholland, M.W. Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells. Peptides, 1995, 16, 927-32.
111. Barrie, A.P.; Clohessy, A.M.; Buensuceso, C.S.; Rogers, M.V.; Allen, J.M. Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a ras-independent, mitogen-activated protein kinase/ERK kinase 1 or 2-dependent manner in PC12 cells. J. Biol. Chem., 1997, 272, 19666-71.
112. Sakai, Y.; Hashimoto, H.; Shintani, N.; Katoh, H.; Negishi, M.; Kawaguchi, C.; Kasai, A.; Baba, A. PACAP activates Rac1 and synergizes with NGF to activate ERK1/2, thereby inducing neurite outgrowth in PC12 cells. Mol. Brain. Res., 2004, 123, 18-26.
113. Rønn, L.C.B.; Hartz, B.P.; Bock, E. The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp. Gerontol., 1998, 33, 853-64.
114. Walmod, P.S.; Kolkova, K.; Berezin, V.; Bock, E. Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem. Res., 2004, 29, 2015-35.
115. Hansen, S.M.; Berezin, V.; Bock, E. Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-Cadherin. Cell. Mol. Life Sci., 2008, 65, 3809-21.
116. Rønn, L.C.B.; Olsen, M.; Soroka, V.; Østergaard, S.; Dissing, S.; Poulsen, F.M.; Holm, A.; Berezin, V.; Bock, E. Characterization of a novel NCAM ligand with a stimulatory effect on neurite outgrowth identified by screening a combinatorial peptide library. Eur. J. Neurosci., 2002, 16, 1720-30.
117. Neiiendam, J.L.; Køhler, L.B.; Christensen, C.; Li, S.Z.; Pedersen, M.V.; Ditlevsen, D.K.; Kornum, M.K.; Kiselyov, V.V.; Berezin, V.; Bock, E. An NCAM-derived FGF-receptor agonist, the FGLpeptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J. Neurochem., 2004, 91, 920-35.
118. Cambon, K.; Hansen, S.M.; Venero, C.; Herrero, A.I.; Skibo, G.; Berezin, V.; Bock, E.; Sandi, C. A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation. J. Neurosci., 2004, 24, 4197-204.
119. Køhler, L.B.; Soroka, V.; Korshunova, I.; Berezin, V.; Bock, E. A peptide derived from a trans-homophilic binding site in neural cell adhesion molecule induces neurite outgrowth and neuronal survival. J. Neurosci. Res., 2010, 88, 2165-76.
120. Rønn, L.C.B.; Dissing, S.; Holm, A.; Berezin, V.; Bock, E. Increased intracellular calcium is required for neurite outgrowth induced by a synthetic peptide ligand of NCAM. FEBS Lett., 2002, 518, 60-66.
121. NTR receptors and stimulate neurite outgrowth and survival. J. Neurosci. Res., 2010, 88, 1170-81.
122. Ralets, I.; Østergaard, S.; Holm, A.; Køhler, L.; Bock, E.; Berezin, V. Identification of neurite extension inducing peptides by means of soluble combinatorial peptide libraries. J. Neurosci. Methods., 2004, 137, 61-69.
123. Hirata, K.; Yamaguchi, H.; Takamura, Y.; Takagi, A.; Fukushima, T.; Iwakami, N.; Saitoh, A.; Nakagawa, M.; Yamada, T. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-Benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid -β- induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons. J. Pharmacol. Exp. Ther., 2005, 314, 252-59.
124. Fukushima, T.; Koide, M.; Ago, Y.; Baba, A.; Matsuda, T. T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons. Neurochem. Int., 2006, 48, 124-30.
125. Nguyen, P.T.H.; Kimura, T.; Ho, S.A.; Tran, A.H.; Ono, T.; Nishijo, H. Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid- β peptide (1-40) in rats. Hippocampus, 2007, 17, 443-55.
126. Yamashita, D.; Shiotani, A.; Kanzaki, S.; Nakagawa, M.; Ogawa, K. Neuroprotective effects of T-817MA against noise-induced hearing loss. Neurosci. Res., 2008, 61, 38-42.
127. Li, Y.S.; Matsunaga, K.; Kato, R.; Ohizumi, Y. Verbenachalcone, a novel dimeric dihydrochalcone with potentiating activity on nerve growth factor-action from Verbena littoralis. J. Nat. Prod., 2001, 64, 806-08.
128. Xing, X.C.; Padmanaban, D.; Yeh, L.A.; Cuny, G.D. Utilization of a copper-catalyzed diaryl ether synthesis for the preparation of verbenachalcone. Tetrahedron, 2002, 58, 7903-10.
129. Yeh, L.A.; Padmanaban, D.; Ho, P.; Xing, X.C.; Rowley, P.; Morse, L.J.; Jensen, R.V.; Cuny, G.D. Effects of a verbenachalcone derivative on neurite outgrowth, inhibition of caspase induction and gene expression. Bioorg. Med. Chem. Lett., 2005, 15, 1193-96.
130. Clement, C.M.; Dandepally, S.R.; Williams, A.L.; Ibeanu, G.C. A synthetic analog of verbenachalcone potentiates NGF-induced neurite outgrowth and enhances cell survival in neuronal cell models. Neurosci. Lett., 2009, 459, 157-61.
131. Forman, B.M.; Tontonoz, P.; Chen, J.; Brun, R.P.; Spiegelman, B.M.; Evans, R.M. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell, 1995, 83, 803-12.
132. Satoh, T.; Furuta, K.; Suzuki, M.; Watanabe, Y. Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells. Biochem. Biophys. Res. Commun., 1999, 258, 50-53.
133. Tanaka, H.; Hasegawa, T.; Kita, N.; Nakahara, H.; Shibata, T.; Oe, S.; Ojika, M.; Uchida, K.; Takahashi, T. Polymer-assisted solutionphase synthesis and neurite-outgrowth-promoting activity of 15- deoxy-β12,14-PGJ2 derivatives. Chem. Asian J., 2006, 1, 669-77.
134. 12,14-prostaglandin J2. Mol. Pharmacol., 2003, 63, 607-16.
135. Hatanaka, M.; Shibata, N.; Shintani, N.; Haba, R.; Hayata, A.; Hashimoto, H.; Baba, A. 15d-Prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor-homologous molecule expressed on THelper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. J. Pharmacol. Sci., 2010, 113, 89-93.
136. Lin, C.W.; Wu, M.J.; Liu, I.Y.C.; Su, J.D.; Yen, J.H. Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERKdependent induction of Nrf2-driven HO-1 expression. J. Agric. Food Chem., 2010, 58, 4477-86.
137. Kano, Y.; Horie, N.; Doi, S.; Aramaki, F.; Maeda, H.; Hiragami, F.; Kawamura, K.; Motoda, H.; Koike, Y.; Akiyama, J.; Eguchi, S.; Hashimoto, K. Artepillin C derived from propolis induces neurite outgrowth in PC12m3 cells via ERK and p38 MAPK pathways. Neurochem. Res., 2008, 33, 1795-803.
138. Ina, A.; Hayashi, K.I.; Nozaki, H.; Kamei, Y. Pheophytin a, a low molecular weight compound found in the marine brown alga Sargassum fulvellum, promotes the differentiation of PC12 cells. Int. J. Devl Neurosci., 2007, 25, 63-68.
139. Hur, J.Y.; Lee, P.; Kim, H.; Kang, I.; Lee, K.R.; Kim, S.Y. (-)-3,5- Dicaffeoyl-muco-quinic acid isolated from Aster scaber contributes to the differentiation of PC12 cells: through tyrosine kinase cascade signaling. Biochem. Biophys. Res. Commun., 2004, 313, 948-53.
140. Shin, J.S.; Kim, Y.M.; Hong, S.S.; Kang, H.S.; Yang, Y.J.; Lee, D.K.; Hwang, B.Y.; Ro, J.S.; Lee, M.K. Induction of neurite outgrowth by (-)-(7R, 8S)-dihydrodehydrodiconiferyl alcohol from PC12 cells. Arch. Pharm. Res., 2005, 28, 1337-40.
141. Fukuyama, Y.; Nakade, K.; Minoshima, Y.; Yokoyama, R.; Zhai, H.F.; Mitsumoto, Y. Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorg. Med. Chem. Lett., 2002, 12, 1163-66.
142. Ito, M.; Sakai, N.; Ito, K.; Mizobe, F.; Hanada, K.; Mizoue, K. A novel fungal metabolite NG-061 enhances and mimics neurotrophic effect of nerve growth factor (NGF) on neurite outgrowth in PC12 cells. J. Antibiotics., 1999, 52, 224-30.